1. Home
  2. PDFS vs COLL Comparison

PDFS vs COLL Comparison

Compare PDFS & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PDF Solutions Inc.

PDFS

PDF Solutions Inc.

HOLD

Current Price

$30.45

Market Cap

1.2B

Sector

Technology

ML Signal

HOLD

Logo Collegium Pharmaceutical Inc.

COLL

Collegium Pharmaceutical Inc.

HOLD

Current Price

$48.66

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PDFS
COLL
Founded
1992
2002
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.5B
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
PDFS
COLL
Price
$30.45
$48.66
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
6
Target Price
$31.00
$47.50
AVG Volume (30 Days)
257.0K
494.7K
Earning Date
02-12-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
1.63
Revenue
$206,706,000.00
$757,067,000.00
Revenue This Year
$24.23
$26.35
Revenue Next Year
$19.28
$3.67
P/E Ratio
N/A
$29.06
Revenue Growth
21.23
26.34
52 Week Low
$15.91
$23.23
52 Week High
$32.34
$50.79

Technical Indicators

Market Signals
Indicator
PDFS
COLL
Relative Strength Index (RSI) 54.78 58.37
Support Level $28.51 $44.51
Resistance Level $32.34 $50.79
Average True Range (ATR) 1.05 1.45
MACD 0.14 -0.40
Stochastic Oscillator 61.78 63.89

Price Performance

Historical Comparison
PDFS
COLL

About PDFS PDF Solutions Inc.

PDF Solutions Inc offers products and services designed to empower engineers and data scientists across the semiconductor ecosystem to improve the yield, quality, and profitability of their products. The solutions combine proprietary software, physical intellectual property (or IP) for integrated circuit (or IC) designs, electrical measurement hardware tools, various methodologies, and professional services. The company's products and services are sold to integrated device manufacturers (or IDMs), fabless semiconductor companies, foundries, outsourced semiconductor assembly and test (or OSATs), and system houses.

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.

Share on Social Networks: